» Articles » PMID: 20156174

Natural Polyphenols That Display Anticancer Properties Through Inhibition of Kinase Activity

Overview
Journal Curr Med Chem
Specialty Chemistry
Date 2010 Feb 17
PMID 20156174
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Over eleven hundred publications reporting anticancer activities of polyphenols have appeared in the peer-reviewed literature. In addition, a search of the PubMed database using "polyphenols - cancer - review" as keywords produced over 320 hits for review articles (July 2009). Polyphenol anticancer activities include, among others, anti-oxidative, pro-apoptotic, DNA damaging, anti-angiogenic, and immunostimulatory effects. Targeting specific protein kinases to combat cancer represents a major focus of oncology research within the so-called targeted therapy approach. An exhaustive search of the PubMed database (July 2009) using "polyphenols - cancer - kinases" as keywords resulted in more than 130 hits, half of them having been published within the past five years. Furthermore, the PubMed database contains 25 reviews on the subject of anti-kinase activity of some specific polyphenols, including mainly curcumin and the green tea polyphenol (-)-epigallocatechin 3-gallate (EGCG). However, no attempt has been made yet to review this area of research in a comprehensive, general manner. The current review therefore aims to highlight those anticancer polyphenols that target specific kinases in various types of cancer. The present review also provides an in-depth analysis of polyphenol structure- activity relationships in relation to their anticancer activities and specific kinase targeting. Lastly, a number of polyphenols are identified as potential antitumor agents that could be used to combat biologically aggressive cancers, including metastasizing cancers, through the targeting of specific kinases.

Citing Articles

Down syndrome and DYRK1A overexpression: relationships and future therapeutic directions.

Murphy A, Wilton S, Aung-Htut M, McIntosh C Front Mol Neurosci. 2024; 17:1391564.

PMID: 39114642 PMC: 11303307. DOI: 10.3389/fnmol.2024.1391564.


-Benzylated 5-Hydroxybenzothiophene-2-carboxamides as Multi-Targeted Clk/Dyrk Inhibitors and Potential Anticancer Agents.

Mostafa N, Chen P, Darwish S, Su Y, Shiao M, Piazza G Cancers (Basel). 2024; 16(11).

PMID: 38893153 PMC: 11171218. DOI: 10.3390/cancers16112033.


Quercetin Effects on Cell Cycle Arrest and Apoptosis and Doxorubicin Activity in T47D Cancer Stem Cells.

Azizi E, Fouladdel S, Movahhed T, Modaresi F, Barzegar E, Ghahremani M Asian Pac J Cancer Prev. 2022; 23(12):4145-4154.

PMID: 36579996 PMC: 9971456. DOI: 10.31557/APJCP.2022.23.12.4145.


Polyphenol Mechanisms against Gastric Cancer and Their Interactions with Gut Microbiota: A Review.

Li M, Zheng Y, Zhao J, Liu M, Shu X, Li Q Curr Oncol. 2022; 29(8):5247-5261.

PMID: 35892986 PMC: 9332243. DOI: 10.3390/curroncol29080417.


Scalable Synthesis and Cancer Cell Cytotoxicity of Rooperol and Analogues.

Schwartz Z, Theisen P, Bjornstal O, Rodebaugh M, Jemal M, Lee D Molecules. 2022; 27(6).

PMID: 35335155 PMC: 8949049. DOI: 10.3390/molecules27061792.